Revance Therapeutics, Inc.

RVNC · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$137,329$108,965$110,623$333,558
Short-Term Investments$116,586$231,742$114,448$102,947
Receivables$27,676$11,339$3,348$1,829
Inventory$45,579$18,325$10,154$5,876
Other Curr. Assets$11,695$4,356$7,544$5,793
Total Curr. Assets$338,865$374,727$246,117$450,003
Property Plant & Equip (Net)$90,207$67,755$69,001$47,131
Goodwill$0$77,175$146,964$146,964
Intangibles$9,808$27,004$55,334$71,343
Long-Term Investments$6,870$6,052$5,046$3,445
Tax Assets$0-$6,052-$5,046-$3,445
Other NC Assets$32,704$35,239$13,747$4,779
Total NC Assets$139,589$207,173$285,046$270,217
Other Assets$0$0$0$0
Total Assets$478,454$581,900$531,163$720,220
Liabilities
Payables$13,809$4,546$10,603$12,657
Short-Term Debt$10,854$4,912$4,746$8,874
Tax Payable$0$0$0$0
Deferred Revenue$10,737$6,867$9,362$7,851
Other Curr. Liab.$53,824$59,357$42,578$31,582
Total Curr. Liab.$89,224$75,682$67,289$60,964
LT Debt$467,580$413,556$319,766$27,146
Deferred Rev, NC$70,419$78,577$74,152$77,294
Deferred Tax Liab, NC$0$0$0$180,526
Other NC Liab.$2,835$1,485$1,485$0
Total NC Liab.$540,834$493,618$395,403$284,966
Other Liabilities$0$0$0$0
Cap. Leases$49,339$39,094$43,877$31,583
Total Liabilities$630,058$569,300$462,692$345,930
Equity
Pref Stock$0$0$0$0
Common Stock$88$82$72$69
Retained Earnings-$2,078,360-$1,754,374-$1,397,952-$1,126,293
AOCI$14-$374-$18$0
Other Equity$1,926,654$1,767,266$1,466,369$1,500,514
Total Equity-$151,604$12,600$68,471$374,290
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$478,454$581,900$531,163$720,220
Net Debt$341,105$309,503$213,889-$297,538